Postmarket Drug Safety: The View From the FDA

Two recent studies have raised potential concerns about the safety of newly approved drugs. What is the FDA’s safety monitoring process, and are changes needed? Medscape spoke with FDA to find out.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s